Kresmion signals archive
615 cross-asset signals fired across commodity, crypto, equity, forex, macro. See also the Kresmion brief for 2026-05-02.
commodity (1)
OSINT: Energy commodity prices surge over 70% since Jan 1, 2026
crypto (3)
ETH ETF outflow of $177M - institutional selling
BTC ETF outflow of $165M - institutional selling
USDC/USDT has $65.2M volume but only $884K liquidity - thin market, slippage risk
equity (196)
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves COLESTID (Pfizer) - new revenue stream
FDA approves COLESTID (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves SYNAREL (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves COLESTID (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves HEMABATE (Pfizer) - new revenue stream
FDA approves NORPACE CR (Pfizer) - new revenue stream
FDA approves HEMABATE (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves SYNAREL (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves LINEZOLID (Pfizer) - new revenue stream
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves CYKLOKAPRON (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves NORPACE CR (Pfizer) - new revenue stream
FDA approves LINEZOLID (Pfizer) - new revenue stream
FDA approves MEDROL (Pfizer) - new revenue stream
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves NORPACE CR (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves SYNAREL (Pfizer) - new revenue stream
FDA approves LINEZOLID (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves HEMABATE (Pfizer) - new revenue stream
FDA approves VELSIPITY (Pfizer) - new revenue stream
FDA approves MEDROL (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves VELSIPITY (Pfizer) - new revenue stream
FDA approves CYKLOKAPRON (Pfizer) - new revenue stream
FDA approves VELSIPITY (Pfizer) - new revenue stream
FDA approves CYKLOKAPRON (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves MEDROL (Pfizer) - new revenue stream
FDA approves ZYVOX (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves drug (Pfizer) - new revenue stream
FDA approves CANCIDAS (Merck) - new revenue stream
FDA approves CANCIDAS (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves CANCIDAS (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Merck) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves ALIMTA (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves HUMATROPE (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves EVISTA (Lilly) - new revenue stream
FDA approves HUMATROPE (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves INSULIN LISPRO (Lilly) - new revenue stream
FDA approves INSULIN LISPRO (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves ALIMTA (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves ALIMTA (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves EVISTA (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves HUMATROPE (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves EVISTA (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves INSULIN LISPRO (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Lilly) - new revenue stream
FDA approves drug (Gilead) - new revenue stream
FDA approves drug (Gilead) - new revenue stream
FDA approves drug (Gilead) - new revenue stream
FDA approves TRUVADA (Gilead) - new revenue stream
FDA approves TRUVADA (Gilead) - new revenue stream
FDA approves TRUVADA (Gilead) - new revenue stream
FDA approves LETAIRIS (Gilead) - new revenue stream
FDA approves LETAIRIS (Gilead) - new revenue stream
FDA approves CAYSTON (Gilead) - new revenue stream
FDA approves CAYSTON (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves EMTRIVA (Gilead) - new revenue stream
FDA approves CAYSTON (Gilead) - new revenue stream
FDA approves LETAIRIS (Gilead) - new revenue stream
FDA approves CAMZYOS (Bristol) - new revenue stream
FDA approves CAMZYOS (Bristol) - new revenue stream
FDA approves drug (Bristol) - new revenue stream
FDA approves drug (Bristol) - new revenue stream
FDA approves SOTYKTU (Bristol) - new revenue stream
FDA approves SOTYKTU (Bristol) - new revenue stream
FDA approves ONUREG (Bristol) - new revenue stream
FDA approves CAMZYOS (Bristol) - new revenue stream
FDA approves ONUREG (Bristol) - new revenue stream
FDA approves ONUREG (Bristol) - new revenue stream
FDA approves drug (Bristol) - new revenue stream
FDA approves drug (Bristol) - new revenue stream
FDA approves POMALYST (Bristol) - new revenue stream
FDA approves POMALYST (Bristol) - new revenue stream
FDA approves POMALYST (Bristol) - new revenue stream
FDA approves EVOTAZ (Bristol) - new revenue stream
FDA approves EVOTAZ (Bristol) - new revenue stream
FDA approves EVOTAZ (Bristol) - new revenue stream
FDA approves AVONEX (Biogen) - new revenue stream
FDA approves AVONEX (Biogen) - new revenue stream
FDA approves drug (Biogen) - new revenue stream
FDA approves drug (Biogen) - new revenue stream
FDA approves drug (Biogen) - new revenue stream
FDA approves BLINCYTO (Amgen) - new revenue stream
FDA approves PROLIA (Amgen) - new revenue stream
FDA approves PROLIA (Amgen) - new revenue stream
FDA approves PROLIA (Amgen) - new revenue stream
FDA approves NPLATE (Amgen) - new revenue stream
FDA approves NPLATE (Amgen) - new revenue stream
FDA approves NPLATE (Amgen) - new revenue stream
FDA approves VECTIBIX (Amgen) - new revenue stream
FDA approves VECTIBIX (Amgen) - new revenue stream
FDA approves VECTIBIX (Amgen) - new revenue stream
FDA approves NEULASTA (Amgen) - new revenue stream